Cancer Check Labs is live in 44 states and has the ability to test for any solid tumor with a 40 ml blood draw.

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

The tissue-based test is approved to identify a new classification in HER2 expression designated as HER2-ultralow.

The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, ...

An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.

Pathologists supported by a new artificial intelligence tool outperformed Standard of Care/Gold standard in determining ...

Australian researchers achieve a breakthrough in improving breast cancer cure rates, offering new hope for patients worldwide ...

Patients might not know about Roche Tissue Diagnostics, but the Arizona entity has been testing for cancer and helping devise ...

The organization is leveraging its growing bank of whole-slide pathology images to create models that could form the backbone of cancer testing applications.

The Global Matrigel Market is projected to grow from USD 85 Million in 2024 to USD 163.3 Million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period. The Global ...

ALAFIA’s Aivas supercomputer for healthcare won two innovation awards at this year’s CES event in Las Vegas, Nevada.

"Traditionally, tissue biopsies are examined under a microscope. By digitising these slides, computers can now visualise them ... making it one of Asia's largest datasets. "Effective cancer management ...